PAG
MREO

Private Advisor Group’s Mereo BioPharma MREO Stock Holding History

Private Advisor Group’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-255
Closed -$1K – 2721
2020
Q2 		$1K Buy
+255
New +$450 ﹤0.01% 3734

Other funds holding MREO

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Private Advisor Group's MREO Position: Q3 2020 in Review

Private Advisor Group sold out of Mereo BioPharma (MREO) in Q3 2020, closing a stake of 255 shares — an estimated $1K sold.

Private Advisor Group first reported a position in MREO in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 28 funds tracked by Wall St. Rank hold MREO as of Q3 2020.

  • Private Advisor Group reported no remaining Mereo BioPharma position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 255 Mereo BioPharma shares in Q3 2020, an estimated $1K.
  • Private Advisor Group first reported a position in Mereo BioPharma in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Mereo BioPharma position peaked at $1K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.